Investment Focus

We invest in companies in the biotechnology and medical technology sector with a high level of relevance for the current and future business model of Novo Nordisk. We invest in companies possessing all the following criteria:

Pioneering scientific ideas/technologies
A strong management
A strong IPR position
A strong financial prospect

Our focus areas of investment are:

Biotech companies addressing new treatment regimes of Diabetes
Biotech companies with strong competencies within biopharmaceuticals addressing therapeutics areas such as Inflammation and Haemostasis
Biotech companies with Novel Protein technologies, Delivery Systems and Devices